|
|||
|
Multiple Sclerosis Info
|
Sunday, February 10
Natalizumab Has Benefits on Disability
by
All About MS
on Sun 10 Feb 2008 10:29 AM CST
natalizumab results in significant improvements in scores on health-related quality of life (QoL) questionnaires in patients more »
Long-term (up to 22 years), study of glatiramer acetate (Copaxone) in relapsing remitting multiple sclerosis.
by
All About MS
on Sun 10 Feb 2008 12:00 AM CST
To evaluate the safety and efficacy of long-term glatiramer acetate (GA) therapy, 46 patients with relapsing remitting multiple sclerosis (RRMS) were treated for up to 22 years in an ongoing, open-label more »
|
||
